News Overview

Fesoterodine Fumarate Extended-Release Tablets, 4 mg, and 8 mg have an estimated market size of US$ 225 million for twelve months ending September 2021 according to IQVIA.

The company’s board had given approval for the acquisition of a portfolio of brands, for use and commercialization within India, from SPL.

Revenue from operations of the company was at Rs131.72cr in Q3 FY22 as against Rs97.50cr in Q3 FY21 yoy.

The Board Meeting of Greenlam Industries will be held on Tuesday, February 08, 2022, inter alia, to consider and approve the Un-Audited Standalone and Consolidated Financial Results.

The company reported a total income of Rs 1,248.44 crore for Q3 FY’22 as against Rs 1,221.62 crore for Q3 FY’21, reporting growth of 2.20% YoY.

Gross Margin was negatively impacted by higher cost of goods sold (+28%) due to increased raw material prices across all categories.

For the nine months period EBITDA was at Rs564cr, a de-growth of 11.4% over the same period of 2020-21.

The company’s revenue rose 18.7% yoy to Rs11,4501cr in Q3FY22.

Gold stayed largely supported amid a heavy slide in the US dollar index but overall movement was sideways. COMEX Gold futures steadied around $1800 per ounce mark. The overall setup appears to be turning cautious after a sharp tumble last week that took the metal near three week low of $1780 per ounce. A steady rebound in Bitcoin from multi month lows also capped the […]

Crude oil futures moved up in volatile trades. The prices fell sharply on profit selling but good buying was seen in intraday moves as traders eyed sanctions on Russia owing to the Ukraine crisis. The outlook towards US fuel consumption also remained generally favorable amid falling Covid-19 cases. Coronavirus infections in the United Sates reduced by 42 percent in the last fortnight. The latest weekly […]